Search
Close this search box.

Maintaining a Healthy Lifestyle May Reduce Genetic Risk of Early Death by 62%

Maintaining a healthy lifestyle is not only important for overall well-being, but new research suggests it may also play a...

Living a healthy lifestyle can have a significant impact on reducing the risk of early death, even for individuals with...

The Food and Drug Administration (FDA) has recently approved an Investigational New Drug (IND) application for VYN202, a novel BD2-selective...

The Indian Pharmacopoeia Commission (IPC) and the Council of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTech) have recently announced...

A recent Phase 2 clinical trial of the lead NOX inhibitor candidate, setanaxib, has shown promising results in the treatment...

The Food and Drug Administration (FDA) has recently approved Myhibbin (mycophenolate mofetil) oral suspension for the prevention of organ rejection...

BioPharma Services, a leading contract research organization (CRO) specializing in early-phase clinical trials, has recently announced that they have received...

The Association of Clinical Research Professionals (ACRP) recently released its 2024 report, highlighting the challenges faced by the clinical research...

A recent Phase 2 clinical trial has shown promising results for the use of Erleada in combination with androgen deprivation...

Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin lymphoma that typically affects older adults. While advancements...

Endometriosis is a common yet often misunderstood condition that affects millions of women worldwide. It occurs when tissue similar to...

A recent study has revealed promising results that suggest blood pressure medication may not only help lower blood pressure, but...

Amolyt Pharma, a biopharmaceutical company focused on developing innovative treatments for rare endocrine and metabolic diseases, recently announced that the...

The Environmental Protection Agency (EPA) has recently announced a significant allocation of $3 billion for the nationwide replacement of lead...

A new vaccine has shown promising results in protecting against a drug-resistant superbug in mice, according to a recent study...

Clinical research professionals play a crucial role in the development of new treatments and therapies for cancer patients. As part...

A recent study published in the journal Obesity has found that when it comes to weight loss, the number of...

When conducting a research study, selecting appropriate endpoints is crucial in order to accurately measure the outcomes of the study....

A promising new development has emerged in the field of cancer treatment, specifically for patients with B-cell lymphoma. The Phase...

The clinical trials industry plays a crucial role in the development of new medical treatments and therapies. In recent years,...

Summer camp can be a fun and exciting experience for children, but for those with allergies and asthma, it can...

Clinical trials are a crucial component of the medical research process, helping to determine the safety and effectiveness of new...

HealthTech, or healthcare technology, has revolutionized the way clinical trials are conducted in the medical field. With the integration of...

In the world of healthcare and clinical research, the use of technology has become increasingly important in collecting and analyzing...

Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer that accounts for approximately 15% of all...

Relyvrio, a controversial drug used to treat ALS (amyotrophic lateral sclerosis), is being pulled off the market by its maker,...

Pharmacovigilance is a crucial aspect of the healthcare industry that focuses on monitoring and assessing the safety of pharmaceutical products....

A groundbreaking Phase 2a clinical trial of regenerative cell therapy for end-stage liver disease has recently begun, with the first...

Wet age-related macular degeneration (AMD) is a chronic eye disease that can cause severe vision loss in older adults. It...

A new study published in Drugs.com MedNews has shown promising results for a transdermal microporation system using zolmitriptan in the...

ACRP 2024 Highlights Workforce and Patient Engagement Issues in Clinical Research

The Association of Clinical Research Professionals (ACRP) recently released a report titled “ACRP 2024: Workforce and Patient Engagement in Clinical Research,” which highlights key issues facing the industry in the coming years. The report sheds light on the challenges and opportunities for improving workforce and patient engagement in clinical research, with the goal of enhancing the quality and efficiency of clinical trials.

One of the key findings of the report is the growing demand for skilled professionals in the clinical research field. As the number of clinical trials continues to rise, there is a need for a larger workforce with specialized training and expertise in areas such as regulatory compliance, data management, and patient recruitment. The report emphasizes the importance of investing in training and development programs to ensure that the industry has a well-equipped workforce to meet the demands of the future.

In addition to workforce issues, the report also highlights the importance of patient engagement in clinical research. Patient recruitment and retention are critical factors in the success of clinical trials, yet many studies struggle to enroll enough participants or retain them throughout the duration of the trial. The report suggests that improving patient engagement through education, communication, and support services can help to address these challenges and ultimately improve the quality and efficiency of clinical research.

The report also addresses the need for greater diversity and inclusion in clinical research. Historically, clinical trials have been conducted primarily on white, male participants, leading to a lack of diversity in study populations. This can have significant implications for the generalizability of study results and the effectiveness of treatments for all patient populations. The report calls for increased efforts to recruit a more diverse range of participants in clinical trials, as well as to ensure that research teams are representative of the communities they serve.

Overall, the ACRP 2024 report highlights the importance of addressing workforce and patient engagement issues in clinical research to ensure that studies are conducted efficiently, ethically, and with the best interests of patients in mind. By investing in training programs, improving patient engagement strategies, and promoting diversity and inclusion in research, the industry can work towards a more effective and inclusive approach to clinical trials.